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To investigate whether genome sequencing yields more useful markers than those currently used to study the
epidemiology of tuberculosis, it was applied to three Mycobacterium tuberculosis isolates of the Harlingen
outbreak. Our findings suggest that single nucleotide polymorphisms can be used to identify transmission
chains in restriction fragment length polymorphism clusters.
Molecular typing contributes significantly to our understand-
ing of the epidemiology of tuberculosis. A variety of genetic mark-
ers, such as IS6110 restriction fragment length polymorphism
(RFLP) and variable-number tandem repeat (VNTR) typing, are
currently used for DNA fingerprinting of Mycobacterium tuber-
culosis isolates (2, 7, 12–14, 23). Unfortunately, these markers
do not distinguish primary and subsequent sources of infection
in long-term DNA fingerprinting surveillance, as the turnover
of these markers is not in range with the pace of transmission
(4–6). Therefore, molecular typing is inaccurate when applied
for extended time periods in a given area.
In the Netherlands, IS6110 RFLP typing has been routinely
used for molecular epidemiology since the early 1990s. A re-
markably large outbreak began in the city of Harlingen in 1992,
and this cluster grew to over 100 cases in 2008 and is still
expanding (10, 11). Although a small subset of isolates of this
cluster exhibited a single transposition or deletion of IS6110, it
soon became impossible to distinguish sources of infection and
secondary and subsequent cases in the cluster. Some contact
chains in the Harlingen cluster were suggested by contact trac-
ing, performed according to the stone-in-the-pond principle
(15, 25), but the exact transmission chains could not be vali-
dated by fingerprinting of the M. tuberculosis isolates, as most
of the isolates revealed the same DNA fingerprints.
For this study, three isolates from two chains of transmission
in the Harlingen cluster that could be accurately determined by
contact tracing were selected for genome sequencing (Fig. 1).
The bacterial isolates exhibited no change in antituberculosis
drug resistance or any other observable change in phenotype.
Sequencing and analysis of strains SH1 and SH5, as well as the
tempo and mode of evolutionary changes between these two
isolates, were described in one of our earlier studies (19). The
DNA of strain SH9, purified according to the method of van
Soolingen et al. (24), was de novo sequenced on a GS FLX
Titanium system, and assembly of raw sequencing reads with
an average read length of 400 bases was performed by using
the Genome Sequencer software, version 2.0.0.22. Sequence
reads, contigs, and quality scores were provided by Microsynth
AG, Switzerland. The SH9 sequence consisted of 214,283,462
high-quality bases assembled in 401 contigs with 4,207,440
bases (50.9-fold coverage). In total, 95.4% of the theoretical
genome size of 4.41 Mb was available for analysis. From the in
silico comparison of the three genomes, eight polymorphic
single nucleotide polymorphisms (SNPs) were verified by sub-
sequent resequencing on an ABI 3730xl sequencer (Table 1).
All 104 isolates of the IS6110 Harlingen cluster were tested
for the presence of these eight SNPs. The bacterial isolates
were designated with an “S” (for strain) followed by their
patient number (for example, H44 for Harlingen patient 44).
Identified polymorphic sites were concatenated, and these
aligned sequences were clustered using a neighbor-joining al-
* Corresponding author. Mailing address: National Mycobacteria Ref-
erence Laboratory, National Institute for Public Health and the Environ-
ment (RIVM), Centre for Infectious Disease Control (CIb/LIS, pb22),
P.O. Box 1, 3720 BA Bilthoven, Netherlands. Phone: 31-30-2742363. Fax:
31-30-2744418. E-mail: Dick.van.Soolingen@rivm.nl.
 Published ahead of print on 30 June 2010.
FIG. 1. Schematic depiction of two contact chains from the Harlin-
gen (H) cluster suggested by contact tracing. Time is depicted by the
horizontal bar; patients are numbered H1 to H9. Bacterial isolates of
patients marked with an asterisk were subjected to genome sequenc-
ing. The bacterial isolates are designated with an “S” (for strain)
followed by the patient number (e.g., SH1, SH5, and SH9). A bacterial
isolate of patient H6 was not available for analysis. #, after being
diagnosed with tuberculosis in 2003, patient H4 experienced two re-
lapses of the disease in 2004 and 2005 (referred to as H4.a, H4.b, and
H4.c in Fig. 3).
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gorithm with ClustalW version 2.0.1 (22), which divided the
Harlingen cluster into five SNP clusters (Fig. 2A).
To assign index cases within an SNP cluster, the dates of
isolation of the strains were included for isolates of patients in
one of the contact chains (Fig. 1) and for isolates in one of the
new SNP clusters. The patient with the earliest isolate in each
SNP cluster was defined as the index case. The earliest iden-
tified case is, however, not necessarily the first source of trans-
mission. Delays in the timely diagnosis of tuberculosis may
occur because of differences in health care-seeking behavior
and lack of symptoms or expertise of care providers. In our
study, the contact tracing information supported the index
cases assigned by this model. For all other isolates, the time
that had passed since the diagnosis of the index case was
calculated and added as separate branches in Fig. 2B.
TABLE 1. Single nucleotide polymorphisms identified by genome
sequencing of three Mycobacterium tuberculosis Harlingen
isolates and used as markers in this study
SNP
no.
Coordinate in
strain H37Rv
Single nucleotide
polymorphism
Polymorphisms first
identified between
the genome
sequences of
strainsa:
1 332,437 G3A SH1 and SH5
2 2,187,212 T3G SH1 and SH5
3 3,611,558 G3A SH1 and SH5
4 4,388,976 G3C SH1 and SH5
5 1,483,748 C3T SH1 and SH9
6 2,976,989 T3C SH1 and SH9
7 3,165,490 G3A SH1 and SH9
8 3,904,206 T3C SH1 and SH9
a Strains are referred to by an “S” followed by the number of the patient from
which the strain was isolated.
FIG. 2. (A) Clustering of the single nucleotide polymorphism (SNP) types of the isolates of the Harlingen IS6110 restriction fragment length
polymorphism (RFLP) cluster. Application of the SNP markers to the isolates of the Harlingen cluster divided the IS6110 RFLP cluster into SNP
clusters. The SNP types of the clusters are shown as an eight-position SNP code. Positions one to four indicate SNPs that were identified between
strains SH1 and SH5 and positions five to eight represent SNPs that were identified between strains SH1 and SH9 (Table 1). Positions in red
represent acquired SNPs, and underlined positions represent mutation events. (B) Dendrogram of clustered SNP types with integration of a time
scale. All bacterial strains are designated with an “S” followed by the respective patient number. Only isolates of patients of one of the contact
chains or strains with an SNP type different from the SNP type of SH1 were used for clustering. Branches in bold indicate the neighbor-
joining-based clustering of the SNP types. Other horizontal branches indicate the number of days that have passed since the isolation date
of the first patient isolate in each transmission cluster. Samples with the same color belong to one SNP cluster. Black, Harlingen cluster; red,
SNP cluster with index case H3; purple, SNP cluster with index case H4.a; blue, SNP cluster with index case H4.c; green, SNP cluster with
index case H9. A bacterial isolate of patient H6 (SH6) is missing from the Dutch tuberculosis database, because this patient was not
diagnosed in the Netherlands.
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By applying genome sequencing data, the number of possi-
ble infection routes was minimized for all patients. For patients
whose isolates were part of the newly identified SNP clus-
ters, a most likely scheme of transmission events was created
(Fig. 3).
For one patient who had had two episodes of tuberculosis, in
1996 (isolate SH88.a) and 1999 (isolate SH88.b), SNP typing
confirmed a suspected reinfection by the Harlingen strain from
a secondary source in the Harlingen outbreak and excluded a
possible endogenous reactivation of the disease. The isolate of
the first disease episode of this patient was part of the largest
cluster (SNP type GTGGCTGT), and the isolate of the second
disease episode exhibited SNP type GTGCCTGT (underlining
represents a mutation event), which supported a reinfection by
patient H3. Patient H88 was married to patient H3; a reinfec-
tion by his partner is in agreement with the contact tracing
information.
Genome sequencing of three isolates of the Harlingen clus-
ter allowed us to determine SNPs and distinguish between
isolates with higher discriminatory power than IS6110 RFLP
and identified separate transmission chains within the cluster.
These SNPs (and their discriminatory power) are specific for
the Harlingen cluster and, for example, are not present in
strain H37Rv, and determination of SNPs in other clusters
requires genome sequencing of patient isolates of those clus-
ters. Although the sequencing of only a few isolates of the
Harlingen outbreak led to a phylogenetic discovery bias (17,
20), i.e., other samples of this IS6110 RFLP cluster most likely
have other SNPs in addition to the ones reported here, it did
not prohibit the disclosure of secondary and tertiary sources
(patients H3 and H4) in the first transmission chain. Moreover,
the first and second isolates of patient H4 exhibited the same
SNP types as isolates of three other patients (patients H81,
H86, and H89) that were infected by this case. In a later year,
patient H4 had a reactivation of tuberculosis, and the isolated
bacteria had another SNP type, also found in the isolates of
another three patients (including patient H5) who were suppos-
edly infected during the reactivation stage of patient H4 (Fig. 3).
The isolates of patients H7 and H8 exhibited no polymor-
phisms compared to SH1. The suggested contact chain leading
to patient H9 was therefore not confirmed by this study. More-
over, no other isolates with the SNPs 5 to 8 were found in the
Harlingen cluster. As all diagnosed active tuberculosis cases in
the Netherlands are part of the Dutch database, it can be
assumed that either patient H9 did not infect other persons in
the Netherlands or infected cases did not (yet) progress to
active disease.
After careful considerations of the costs and the technolog-
ical limitations, genome sequencing will probably become the
new standard method for typing of M. tuberculosis in the future
and will replace existing typing methods because of its higher
discriminatory power (16) and the decreasing prices for se-
quencing (8, 18, 26). Genome sequencing will elucidate trans-
mission chains among patients that are clustered by currently
used DNA fingerprinting methods. Future sequencing tech-
niques will probably identify more polymorphisms between
isolates because of technical progress, such as longer sequenc-
ing reads (1, 9, 21) and improved read accuracies. When ge-
nome sequencing of M. tuberculosis isolates becomes routinely
available, identification, prediction of drug resistance, and ep-
idemiological typing can be included in a single rapid analysis
(3, 26, 27). In summary, we expect that genome sequencing will
become a useful diagnostic tool with unprecedented possibili-
ties.
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